Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Many if not most of the participants who dropped out of the trial may have and probably were due to the COVID pandemic.
Good luck and GOD bless,
From SeekingAlpha:
https://seekingalpha.com/news/4129280-anavex-blarcamesine-slowed-cognitive-decline-phase-2-3-early-alzheimers-trial?mailingid=36216136&messageid=2900&serial=36216136.598&source=email_2900&utm_campaign=rta-stock-news&utm_content=link-3&utm_medium=email&utm_source=seeking_alpha&utm_term=36216136.598
Good luck and GOD bless,
There were approximately 18,440,000 shares of AVXL that are short.
SHORT SQUEEZE on AVXL coming!!!
Good luck and GOD bless,
SHORT SQUEEZE FOR AVXL STOCK!!!
Conclusions
Blarcamesine once orally daily restores autophagy through SIGMAR1 activation.
In the Phase IIb/III clinical trial, blarcamesine demonstrated: üGood comparative safety profile (no ARIA)
üImprovement in ADAS-Cog13 coprimary efficacy endpoint üMeaningful treatment effect on predesignated biomarkers
within the A/T/N spectrum üPromising clinical results:
The positive results from this trial are encouraging as the recent FDA guidance to consider approval may be based on a single cognitive endpoint (like ADAS-Cog) in Early Alzheimer’s disease trials
Did anyone notice that roughly 63.1% of participants taking blarcamesine had at least one APOE e4 allele?
Did anyone notice that at baseline 6.7% of participants had an MMSE score of less than 20.
Good luck and GOD bless,
The bashers, FUDsters and shorters are all very nervous.
AVXL NEWS coming soon!!!
Good luck and GOD bless,
WRONG!!!
The Anavex newsroom
https://www.anavex.com/newsroom
Good luck and GOD bless,
A Letter from the CEO
At Anavex, we thrive on the benefits of collaboration and teamwork in the effort to identify potential CNS breakthroughs. The strength and resilience of patients and their families motivate us to translate breakthroughs into therapeutics. Our vision of transforming people's lives through science is made possible by the talent and passion of our workforce, all of whom bring unique skills, insights and passion.
Community-based partnerships guide our pre-clinical and clinical research to ensure we do not impose unnecessary burdens onto the people we aim to serve. As a science-driven company, we know it is through diversity of thought and community-based collaborations that we can potentially address the disease areas where people are still waiting for treatments.
?
From the youngest person living with Rett syndrome, or Fragile X syndrome, to the oldest person experiencing Alzheimer's disease, or Parkinson's disease dementia, our vision as a company is only made possible if patients have equitable access to healthcare, and we recognize that we have a role to play in helping to address health equity across the healthcare institutional continuum.
?
A Global Burden of Disease study shows that Alzheimer's disease and other dementias are amongst the 3 most burdensome neurological disorders in the U.S. CNS disorders impact a large number of people with a variety of different cultures and personal backgrounds. From infants to the elderly, we are dedicated to addressing the devastating impact of neurological disorders through our proprietary SIGMACEPTOR™ development platform.
A large body of evidence indicates that sigma-1 receptors (SIGMAR1) are important drug targets for a number of neurological disorders. SIGMAR1 are enriched in the central nervous system (CNS) and are the target for the orally available ANAVEX®2-73.
?
We are proud of the journey we have initiated and look forward to continuing the work required to achieve life-saving therapeutic discovery goals.
Christopher U. Missling
Christopher U. Missling, MS, PhD, MBA
President and CEO
What is being shared is the complete data analysis from Anavex’s Phase 2b/3 Alzheimer’s trial.
GOD bless,
The title of the presentation later today is
Tesla shares render of Giga Nevada’s completed Semi factory
https://www.teslarati.com/tesla-render-giga-nevada-semi-factory/
Good luck and GOD bless,
6 ways Tesla is promising to change the world next year, ranked in order of their actual likelihood
https://www.yahoo.com/finance/news/6-ways-tesla-promising-change-155031261.html
Good luck and GOD bless,
Monday will be an interesting day for AVXL stock, after Dr. Sabbagh's presentation at the AAIC meeting on Sunday.
Good luck and GOD bless,
Almost too late buying AVXL stock today
This coming Sunday 28 July 2024 Dr. Marwan N Sabbagh, MD will be make an oral presentation at the 2024 AAIC Meeting concerning the results from the Phase 2b/3 Alzheimer's trial using blarcamesine.
That means that Friday 26 July 2024 will be the last time for the shorts to cover before the AAIC Meeting!!!
Good luck and GOD bless,
Look for a SHORT SQUEEZE running into the close of treading today!!!
Good luck and GOD bless,
Don’t be too late buying AVXL stock today
This coming Sunday 28 July 2024 Dr. Marwan N Sabbagh, MD will be make an oral presentation at the 2024 AAIC Meeting concerning the results from the Phase 2b/3 Alzheimer's trial using blarcamesine.
That means that Friday 26 July 2024 will be the last time for the shorts to cover before the AAIC Meeting!!!
Good luck and GOD bless,
Dr. Marwan Sabbagh latest video regarding Anavex Life Science's blarcamesine
https://reachmd.com/programs/cme/exploring-autophagy-through-sigma-1-receptor-activation-innovative-therapeutics-for-alzheimers-disease-beyond-amyloid-pathways/26516/
Thank you TTT from stocktwits
Good luck and GOD bless,
Coming presentations by Anavex
26 July 2024 three presentations concerning Anavex at the Fragile X conference
27 July 2024 one presentation regarding Anavex at the Fragile X conference
28 July 2024 one presentation concerning Anavex at the Alzheimer’s disease conference
29 July 2024 one presentation concerning Anavex at the Alzheimer’s disease conference
6 presentations in total
Good luck and GOD bless,
Watch, listen and learn
An Australian TV news interview of Ern Heaven and his wife. Ern had Alzheimer's for over 2 years and was declining when he joined the Anavex phase 2a trial of Anavex 2-73. Over a period of a year on the drug, he first stabilized, and then improved. No other drug has ever helped an Alzheimer's patient improve.
According to the 1 year trial results, 6 patients out of the initial 32 had "strong" reactions and showed improvements in one or more tests.
Anavex Explores Autophagy Through Sigma-1 Receptor Activation as Alzheimer’s Disease Therapeutic
https://metapress.com/anavex-explores-autophagy-through-sigma-1-receptor-activation-as-alzheimers-disease-therapeutic/
Thank you Rowdyboy45 on Stocktwits
Good luck and GOD bless,
There were a couple of very interesting after hour buys of AVXL stock today
At 6:33 PM EDT there were 8,000 shares of AVXL bought at a price of $6.90 per share
At 7:48 PM EDT there were 2,930 shares of AVXL bought at a price of $7.09 per share
https://www.nasdaq.com/market-activity/stocks/avxl/after-hours-trades?page=1&rows_per_page=20
Good luck and GOD bless,
Dr. Marwan Sabbagh latest video regarding Anavex Life Science's blarcamesine
https://reachmd.com/programs/cme/exploring-autophagy-through-sigma-1-receptor-activation-innovative-therapeutics-for-alzheimers-disease-beyond-amyloid-pathways/26516/
Thank you TTT from stocktwits
Good luck and GOD bless,
Coming presentations by Anavex
26 July 2024 three presentations concerning Anavex at the Fragile X conference
27 July 2024 one presentation regarding Anavex at the Fragile X conference
28 July 2024 one presentation concerning Anavex at the Alzheimer’s disease conference
29 July 2024 one presentation concerning Anavex at the Alzheimer’s disease conference
6 presentations in total
Good luck and GOD bless,
Expect AVXL stock price to close at or near the high of the day today on rather high buying volume.
Good luck and GOD bless,
This coming Sunday 28 July 2024 Dr. Marwan N Sabbagh, MD will be make an oral presentation at the 2024 AAIC Meeting concerning the results from the Phase 2b/3 Alzheimer's trial using blarcamesine.
That means that Friday 26 July 2024 will be the last time for the shorts to cover before the AAIC Meeting!!!
Good luck and GOD bless,
Elon Musk reveals photos of Dojo D1 Supercomputer cluster — roughly equivalent to 8,000 Nvidia H100 GPUs for AI training
https://www.yahoo.com/tech/elon-musk-reveals-photos-dojo-103032002.html
Good luck and GOD bless,
The actual presentation trial is very very impressive.
If you disagree, then maybe you should short AVXL even more than you already have shorted AVXL.
GOD bless,
He is making a presentation directly about Anavex's blarcamesine Phase 2b/3 trial results.
Good luck and GOD bless,
YES!!! I am expecting new--needle moving info from this presentation!!!
MRI brain volume (atrophy) etc.
Good luck and GOD bless,
The oral session is scheduled for 4:30 PM EDT on Sunday 28 July 2024.
The shorts have to cover on Friday 26 July 2024 if the need to cover before the AAIC presentation.
Good luck and GOD bless,
This coming Sunday 28 July 2024 Dr. Marwan N Sabbagh, MD will be make an oral presentation at the 2024 AAIC Meeting concerning the results from the Phase 2b/3 Alzheimer's trial using blarcamesine.
That means that Friday 26 July 2026 will be the last time for the shorts to cover before the AAIC Meeting!!!
Good luck and GOD bless,
Expect the AVXL share price to close at or near the high of the day on increasing buying volume near the close of trading today.
Good luck and GOD bless,
None of these trials were actually failed trials:
Avatar
Excellence
P2b/3
GOD bless,
Dr. Marwan Sabbagh latest video regarding Anavex Life Science's blarcamesine
https://reachmd.com/programs/cme/exploring-autophagy-through-sigma-1-receptor-activation-innovative-therapeutics-for-alzheimers-disease-beyond-amyloid-pathways/26516/
Thank you TTT from stocktwits
Good luck and GOD bless,
Doc328: Do you believe that the following is in general true or false???